# Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer

> **NCT01167530** · PHASE1 · COMPLETED · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 26 (actual)

## Conditions studied

- Non-small Cell Lung Cancer
- Locally Advanced Disease

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT01167530
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02-26
- **Primary completion:** 2013-07-04
- **Final completion:** 2017-02-09
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01167530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01167530, "Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01167530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*